Medtronic (NYSE:MDT) today announced a number of procedural solutions for spine surgery as part of its Surgical Synergy  platform aimed at creating consistent, predictable and reproducible spine procedures.

The Fridley, Minn.-based company also announced it has surpassed 1,000 patient cases for its Mazor X Stealth Edition since its commercial launch earlier this year. The device uses Medtronic’s Stealth navigation for robot-guided pedicle screw placement during spinal procedures.

Among the new solutions will be the Mazor X Stealth Edition, for which Medtronic intends to expand system capabilities and incorporate it further into its procedural workflows.

Medtronic also touted the SynergyOLIF360 single-position workflow for oblique lateral interbody fusion. The SynergyOLIF360 is designed to eliminate time and cost associated with mid-procedure repositioning by allowing the OLIF procedure to be performed while a patient is on his or her side.

The company plans to combine Titan nanoLOCK surface technology, which increases cellular factors related to bone growth and anti-inflammation, with FiberCel viable bone matrix for new Titan spine interbody devices.

SynergyCorpectomy is Medtronic’s corpectomy system designed to enable pre-surgical planning, real-time navigation, virtual sizing of the implant, 3-D implant placement visualization and confirmation of implant placement. It will feature a new T2 Stratosphere implant, Grafton DBM DBF and the Midas Rex MR8 system.

The Midas Rex MR8 is a high-speed drill system designed for controlled precision, versatile access and compatibility with Stealth navigation to integrate with Medtronic’s other spine technologies.

Medtronic will unveil its new technologies at the North American Spine Society annual meeting in Chicago from Sept. 25 to Sept. 28.

“The breadth of our portfolio is unparalleled, but what truly sets us apart is our deep expertise and experience,” spine president Jacob Paul said in a news release. “Our technologies have been trusted for the treatment of millions of spine patients – and we’re incredibly proud of that. Providing a truly integrated ecosystem of innovative procedural solutions is in our DNA, and it’s how we transform spine outcomes for physicians and their patients.”

Shares of MDT were down -0.3% at $110.52 per share in mid-afternoon trading today.